benzoxonium chloride
A01A - Stomatological preparations
ATC A01AB14
Small molecule
JFDA label: Orofar solution
Indications
Off-label
Chemistry & Properties
| Formula | C23H42ClNO2 |
|---|
| Molecular weight | 400.05 g/mol |
|---|
| IUPAC name | benzyl-dodecyl-bis(2-hydroxyethyl)azanium chloride |
|---|
| CAS | 19379-90-9 |
|---|
| PubChem CID | 29563 |
|---|
| InChIKey | UUSQFLGKGQEVCM-UHFFFAOYSA-M |
|---|
| logP | 4.91 |
|---|
| Polar surface area | 40.46 Ų |
|---|
| H-bond acceptors / donors | 2 / 2 |
|---|
| Drug-likeness (QED) | 0.30 |
|---|
| Lipinski violations | 0 |
|---|
SMILES
CCCCCCCCCCCC[N+](CCO)(CCO)Cc1ccccc1.[Cl-]Biology & Pharmacokinetics
Pharmacokinetics predicted
| Bioavailability | 35.0% |
|---|
| Half-life | 0.543 h |
|---|
| Volume of distribution | 9.963 L/kg |
|---|
| Protein binding | 98.0% |
|---|
| BBB penetrant | Yes |
|---|
Enzyme interactions
| Enzyme | Role | Detail |
|---|
| CYP1A2 | Inhibitor |
— |
| CYP2D6 | Inhibitor |
— |
Transporters
BCRP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)
Registered Products (3)
| Brand | Form / strength | Pack | Agent | Citizen (JOD) |
|---|
| Orofar Lozenges
|
Lozenge 1 mg, 1 mg |
24 Lozenges |
Sukhtian Group |
2.710 |
| Orofar solution
|
Solution 0.5 mg/ml, 0.5 mg/ml |
200 ml |
Nabulsi Drug Store |
5.090 |
| Orofar buccal spray
|
Spray 2 mg/ml, 1.5 mg/ml |
30 ml |
Sukhtian Group |
5.700 |